FIELD: biotechnology.
SUBSTANCE: invention relates to molecular biology. Described is a method for assessing the resistance of squamous cell carcinoma of throat to radiation therapy. Method involves a polymerase chain reaction (PCR) method, which enables to determine the level of expression of microRNA, which is described by protocols for preparing the PCR and the obtained results. PCR involves preparing a solution using a kit comprising a test tube with a mixture of lyophilized 22 primers for 11 microRNA hsa-miR-128-3p, hsa-miR-20a-5p, hsa-miR-17-5p, hsa-let-7e-5p, hsa-miR-135b-5p, hsa-miR-125b-5p, hsa-miR-21-5p, hsa-miR-16-5p, hsa-miR-210, hsa-miR-23a-3p and hsa-miR-34c-5p.
EFFECT: more accurate and reliable assessment of resistance of squamous cell carcinoma of throat to radiation.
2 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ONCOLYTIC VIRAL VECTORS AND USE THEREOF | 2017 |
|
RU2749050C2 |
| METHODS FOR PATHOLOGICAL CHANGES DETECTION IN ORGAN OR SYSTEM OF ORGANS | 2012 |
|
RU2626540C2 |
| ONCOLYTIC VIRAL VECTORS AND THEIR APPLICATION | 2018 |
|
RU2771110C2 |
| ANALYTICAL SYSTEM FOR DIAGNOSING LUNG CANCER USING FREE AND CIRCULATING MICRO-RNAS ASSOCIATED WITH BLOOD CELLS | 2020 |
|
RU2755651C1 |
| BIOMARKERS OF TRAUMATIC BRAIN INJURY | 2017 |
|
RU2771757C2 |
| VERSIONS OF RECOMBINANT AAV AND USE THEREOF | 2015 |
|
RU2738421C2 |
| MARKERS OF TUMOR CELL RESPONSE TO ANTI-CANCER THERAPY | 2014 |
|
RU2664180C2 |
| QUANTITATIVE ESTIMATE has-miR-16-5p, has-miR-425-5p, has-miR-17-5p, has-miR-20a-5p, has-miR-101-3p, has-miR-30D-5p AND has-miR-93-5p IN PERIPHERAL BLOOD PLASMA OF WOMEN AS METHOD FOR NON-INVASIVE DIAGNOSIS OF SEROUS BOUNDARY OVARY ADENOCYSTOMA AND CYSTADENOCARCENOMA | 2018 |
|
RU2688169C1 |
| METHOD FOR DIAGNOSING GLIAL BRAIN TUMORS OF HIGH DEGREE OF MALIGNANCY | 2020 |
|
RU2742413C1 |
| CLOSED-END LINEAR DUPLEX DNA FOR NON-VIRAL GENE TRANSFER | 2017 |
|
RU2752882C2 |
